An Open, Randomised, Cross-Over, Single Centre Pharmacokinetic (Phase I) Study of the Biliary Excretion Following Single Doses of AZD0837, Given in the Duodenum Via a Loc-I-Gut Catheter, Alone or in Combination With Ketoconazole (Once Daily for 4 Days), to Young Healthy Male Subjects.

Trial Profile

An Open, Randomised, Cross-Over, Single Centre Pharmacokinetic (Phase I) Study of the Biliary Excretion Following Single Doses of AZD0837, Given in the Duodenum Via a Loc-I-Gut Catheter, Alone or in Combination With Ketoconazole (Once Daily for 4 Days), to Young Healthy Male Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Dec 2010

At a glance

  • Drugs AZD 0837; Ketoconazole
  • Indications Thromboembolism
  • Focus Pharmacokinetics
  • Sponsors AstraZeneca
  • Most Recent Events

    • 02 Dec 2010 Actual end date changed from Apr 2009 to Mar 2009 as reported by ClinicalTrials.gov.
    • 07 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Jan 2009 Actual start date (Dec 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top